Oyster Point Pharma, Inc. Total Liabilities
Oyster Point Pharma, Inc. had Total Liabilities of $131.40 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2022-11-10
- 2022-09-30: Liabilities $131.40M.
- 2022-06-30: Liabilities $133.16M.
- 2022-03-31: Liabilities $120.73M.
- 2021-12-31: Liabilities $123.08M.
| Period end | Liabilities |
|---|---|
| 2022-09-30 | $131.40M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $133.16M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $120.73M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $123.08M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $57.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $9.72M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $14.12M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $11.25M 10-K · filed 2022-02-24 |
| 2020-09-30 | $9.82M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.17M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.35M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.91M 10-K · filed 2021-02-18 |
| 2019-09-30 | $6.17M 10-Q · filed 2019-12-03 |
| 2018-12-31 | $946.00K 10-K · filed 2020-02-27 |